ALDOMET

This brand name is authorized in Brazil, Ecuador, France, Hong Kong SAR China, Ireland, Japan, Mexico, Nigeria, South Africa, Spain, UK.

Active ingredients

The drug ALDOMET contains one active pharmaceutical ingredient (API):

1	Alphamethyldopa UNII 56LH93261Y - METHYLDOPA
	Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors.
	Read more about Alphamethyldopa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C02AB	Methyldopa	C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting
Discover more medicines within C02AB
C02AB01	Methyldopa (levorotatory)	C Cardiovascular system → C02 Antihypertensives → C02A Antiadrenergic agents, centrally acting → C02AB Methyldopa
Discover more medicines within C02AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1629R
BR	Câmara de Regulação do Mercado de Medicamentos	505609001119416, 505609002115317
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	H6970913, H6980913
ES	Centro de información online de medicamentos de la AEMPS	37932, 53587
FR	Base de données publique des médicaments	60578560, 64651319
GB	Medicines & Healthcare Products Regulatory Agency	13703, 13736, 178957, 178959
HK	Department of Health Drug Office	01954
JP	医薬品医療機器総合機構	2145001F1027, 2145001F2040
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	57518
NG	Registered Drug Product Database	A4-5443
Switch country to Nigeria in order to find specific presentations of ALDOMET
ZA	Health Products Regulatory Authority	C/7.1.3/205